The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.
Peru is a comparatively small pharmaceutical market in Latin America (ranking eighth in terms of sales volume in 2017), with a relatively young and growing population. However, public health spending is expanding at a rapid pace, particularly in ...View more details
India’s is the world’s 10th-largest pharmaceutical market in US dollar terms - with sales of over USD 25bn in 2017 - and the largest generic drug manufacturer and exporter globally. Strong domestic demand and robust exports have ...View more details
The gross value added (GVA) of the Czech pharmaceutical sector amounted to CZK 19.4bn in 2017, increasing by a real 11.1% y/y. The sector accounted for 0.4% of the GDP that year. The pharmaceutical sector employed 9,855 workers in 2017, accounting ...View more details
Although the global pharma & healthcare sector is dominated by large multinational companies, mainly from the developed countries, Latin America has been quickly catching up in building a domestic pharmaceutical production base and expanding the ...View more details
In the third quarter of 2018, China’s pharmaceutical and medicine production declined by 28.5% y/y to 573,000 tonnes, In 2018, many pharmaceutical producers were affected by the ongoing reform for new chemical drugs classification system, and ...View more details
Mexico is the second-largest pharmaceutical market in Latin America, behind only Brazil, with a large and growing population, multiple but underfunded state-run health insurance schemes, and a small but rapidly developing private health insurance ...View more details
Indonesia’s pharmaceutical and healthcare sector is under-developed compared to many other countries in the Association of Southeast Asian Nations (ASEAN). Indonesia has one of the fewest physicians and hospital beds per 1,000 population in the ...View more details
Brazil’s 208mn population has given rise to a sizeable healthcare sector and to the sixth largest pharmaceutical market in the world. In 2017, retail drug sales, based on pharmacy purchase price (PPP), rose by 11.7% y/y to BRL 56.8bn, supported ...View more details
The third quarter of 2018 witnessed a continuous growth of China’s healthcare sector, mostly driven by the online healthcare segment. The growth was attributed to increasing demand for quality healthcare, stimulated by the country’s ...View more details
Colombia is a mid-sized pharmaceutical market in Latin America (ranking fourth in terms of sales volume in 2017, after Brazil, Mexico and Argentina), with a large and growing population, a universal but underfunded social security health insurance ...View more details